Pfizer taking the networked approach to Asian R&D
This article was originally published in Scrip
Executive Summary
Pfizer is adopting a more "virtual" and networked approach to its R&D activities in Asia than it traditionally has in other parts of the world, driven by a desire to tap into the research talent in the region.